Cost-effectiveness of Oral Clodronate Compared with Oral Ibandronate, Intravenous Zoledronate or Intravenous Pamidronate in Breast Cancer Patients

Author： Paterson A   McCloskey E   Redzepovic J   Ott I   Gust R  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.36, Iss.3, 2008-05, pp. : 400-413

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Incremental Cost-Effectiveness Analysis of Intravenous Ganciclovir Versus Oral Ganciclovir in the Maintenance Treatment of Newly Diagnosed Cytomegalovirus Retinitis in Patients with AIDS

By Rachlis A.  

PharmacoEconomics, Vol. 16, Iss. 1, 1999-07 ,pp. : 71-84

Adis International

Access to resources Recommend Favorite

Oral and Intravenous Ibandronate in the Management of Postmenopausal Osteoporosis: A Comprehensive Review

By  

Current Pharmaceutical Design, Vol. 11, Iss. 28, 2005-11 ,pp. : 3711-3728

Bentham Science Publishers

Access to resources Recommend Favorite

Extended Safety Profile of Oral Clodronate After Long-Term Use in Primary Breast Cancer Patients

By Atula S.  

Drug Safety, Vol. 26, Iss. 9, 2003-01 ,pp. : 661-671

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Oral Terbinafine (Lamisil) Compared with Oral Fluconazole (Diflucan) in the Treatment of Patients with Toenail Onychomycosis

By Salo H.   Pekurinen M.  

PharmacoEconomics, Vol. 20, Iss. 5, 2002-01 ,pp. : 319-324

Adis International

Access to resources Recommend Favorite

A pharmacokinetic, pharmacodynamic, and safety study of intravenous cyclophosphamide with an oral casopitant antiemetic regimen in cancer patients

By  

Clinical Pharmacology In Drug Development, Vol. 3, Iss. 2, 2014-03 ,pp. : 93-100

John Wiley & Sons Inc

Access to resources Recommend Favorite